# Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

> **NCT01700010** · PHASE2 · WITHDRAWN · sponsor: **University of Michigan Rogel Cancer Center**

## Conditions studied

- Urothelial Cancer
- Bladder Cancer

## Interventions

- **DRUG:** Lapatinib and Paclitaxel

## Key facts

- **NCT ID:** NCT01700010
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2017-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding issues.
- **Last updated:** 2013-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700010, "Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01700010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*